サウジアラビアの結核患者におけるイソニアジドの有効性および安全性に対する遺伝子ポリモルフィズムの影響
Mai A Alim A Sattar Ahmad1, Huda Mohammed Alkreathy1, Ahmed Ali2
1Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
International journal of genomics
|September 2, 2025
まとめ
サウジアラビアの結核患者における遺伝的変異は,イソニアジド (INH) 薬のレベルと治療結果に影響します. 高濃度のINHは,よりよい臨床反応と相関しており,個別化された医療アプローチを示唆しています.
科学分野:
- ファルマゲノミクス
- 結核に関する研究
- 臨床薬理学
背景:
- 薬物の代謝酵素とトランスポーターの遺伝的多形性は,抗結核薬の有効性に影響する.
- イソニアジド (INH) 反応は,個々の遺伝子構成によって影響されていることが知られている.
研究 の 目的:
- サウジアラビアの結核患者におけるNAT2,CYP2E1,GSTM1遺伝子ポリモルフィズムを分析する.
- INH薬のレベルをモニタリングし,遺伝的変異,肝毒性,および臨床結果との相関性を評価する.
主な方法:
- サウジアラビアの50人の結核患者の6ヶ月の前向きなコホート研究.
- NAT2,CYP2E1,GSTM1の遺伝子タイプ化について
- 血清INH濃度の測定
主要な成果:
- NAT2およびCYP2E1の変異は認められず,GSTM1の変異は68%の患者で認められた.
- GSTM1の有無は,INH濃度や臨床反応に有意な影響を及ぼさなかった.
- 高濃度のINHは,臨床反応の改善と有意に関連していました.
結論:
- 遺伝的および人口学的要因を考慮した個別化された結核治療が推奨されます.
- 製薬遺伝的プロファイリングは,結核患者のイソニアジド治療を最適化することができます.
関連する概念動画
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Factors Affecting Protein-Drug Binding: Patient-Related Factors
112
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
112
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439


